Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2014 May;37(5):497-8.
doi: 10.1007/s40618-014-0065-x. Epub 2014 Mar 22.

The "slower" the better

L Pala  1 , C M Rotella
Affiliations

The "slower" the better

L Pala et al. J Endocrinol Invest. 2014 May.
No abstract available

PubMed Disclaimer

References

    1. Nathan DM, Buse JB, Davidson MB, Ferrannini E, Holman RR, Sherwin R, et al. American Diabetes Association; European Association for Study of Diabetes. Medical management of hyperglycemia in type 2 diabetes: a consensus algorithm for the initiation and adjustment of therapy: a consensus statement of the American Diabetes Association and the European Association for the Study of Diabetes. Diabetes Care. 2009;32(1):193–203. doi: 10.2337/dc08-9025. - DOI - PMC - PubMed
    1. Prospective Diabetes Study (UKPDS) Group Effect of intensive glucose control with metformin on complications in overweight patients with type 2 diabetes (UKPDS 34. Lancet. 1998;352:854–865. doi: 10.1016/S0140-6736(98)07037-8. - DOI - PubMed
    1. Dohahue S, Marathe P, Guld T, Meeker J. The pharmacokinetics and pharmacodynamics of extended-release metformin tablets vs immediate-release metformin in subjects with type 2 diabetes. Diabetes. 2002;51(suppl 2):A468.
    1. Raz I, Delaet I, Goyvaerts H. Safety and efficacy of novel extended-release formulation of metformin in patients with type 2 diabetes. Diabetes. 2000;49(suppl 1):A363.
    1. Schwartz S, Fonseca V, Berner B, Cramer M, Chiang YK, Lewin A. Efficacy, tolerability and safety of a novel once-daily extended-release metformin in patients with type 2 diabetes. Diabetes Care. 2006;29:759–764. doi: 10.2337/diacare.29.04.06.dc05-1967. - DOI - PubMed

MeSH terms

LinkOut - more resources